BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31430565)

  • 61. Phloroglucinol, a clinical-used antispasmodic, inhibits amyloid aggregation and degrades the pre-formed amyloid proteins.
    Xie Y; Lu J; Yang T; Chen C; Bao Y; Jiang L; Wei H; Wu X; Zhao L; He S; Lin D; Liu F; Liu H; Yan X; Cui W
    Int J Biol Macromol; 2022 Jul; 213():675-689. PubMed ID: 35667457
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease.
    Hajieva P; Behl C
    Curr Pharm Des; 2006; 12(6):699-704. PubMed ID: 16472160
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protein folding and misfolding in the neurodegenerative disorders: a review.
    Bolshette NB; Thakur KK; Bidkar AP; Trandafir C; Kumar P; Gogoi R
    Rev Neurol (Paris); 2014 Mar; 170(3):151-61. PubMed ID: 24613386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.
    Walter S; Jumpertz T; Hüttenrauch M; Ogorek I; Gerber H; Storck SE; Zampar S; Dimitrov M; Lehmann S; Lepka K; Berndt C; Wiltfang J; Becker-Pauly C; Beher D; Pietrzik CU; Fraering PC; Wirths O; Weggen S
    Acta Neuropathol; 2019 Feb; 137(2):239-257. PubMed ID: 30426203
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective.
    Pasternak SH; Callahan JW; Mahuran DJ
    J Alzheimers Dis; 2004 Feb; 6(1):53-65. PubMed ID: 15004328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Seeding of proteins into amyloid structures by metabolite assemblies may clarify certain unexplained epidemiological associations.
    Sade D; Shaham-Niv S; Arnon ZA; Tavassoly O; Gazit E
    Open Biol; 2018 Jan; 8(1):. PubMed ID: 29367352
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protein Self-Assembly at the Liquid-Surface Interface. Surface-Mediated Aggregation Catalysis.
    Lyubchenko YL
    J Phys Chem B; 2023 Mar; 127(9):1880-1889. PubMed ID: 36812408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alzheimer's disease: where next for anti-amyloid therapies?
    Hardy J; De Strooper B
    Brain; 2017 Apr; 140(4):853-855. PubMed ID: 28375461
    [No Abstract]   [Full Text] [Related]  

  • 70. The intrinsic amyloidogenic propensity of cofilin-1 is aggravated by Cys-80 oxidation: A possible link with neurodegenerative diseases.
    Kaushik V; Brünnert D; Hanschmann EM; Sharma PK; Anand BG; Kar K; Kateriya S; Goyal P
    Biochem Biophys Res Commun; 2021 Sep; 569():187-192. PubMed ID: 34256187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Anti-amyloid Compound DO1 Decreases Plaque Pathology and Neuroinflammation-Related Expression Changes in 5xFAD Transgenic Mice.
    Boeddrich A; Babila JT; Wiglenda T; Diez L; Jacob M; Nietfeld W; Huska MR; Haenig C; Groenke N; Buntru A; Blanc E; Meier JC; Vannoni E; Erck C; Friedrich B; Martens H; Neuendorf N; Schnoegl S; Wolfer DP; Loos M; Beule D; Andrade-Navarro MA; Wanker EE
    Cell Chem Biol; 2019 Jan; 26(1):109-120.e7. PubMed ID: 30472115
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combining molecular dynamics simulations and experimental analyses in protein misfolding.
    Wille H; Dorosh L; Amidian S; Schmitt-Ulms G; Stepanova M
    Adv Protein Chem Struct Biol; 2019; 118():33-110. PubMed ID: 31928730
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.
    Mazzitelli S; Filipello F; Rasile M; Lauranzano E; Starvaggi-Cucuzza C; Tamborini M; Pozzi D; Barajon I; Giorgino T; Natalello A; Matteoli M
    Acta Neuropathol Commun; 2016 Oct; 4(1):110. PubMed ID: 27724899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
    Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
    Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.
    Hirohata M; Ono K; Yamada M
    Curr Pharm Des; 2008; 14(30):3280-94. PubMed ID: 19075706
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease.
    Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Takenouchi T; Waragai M; Masliah E
    J Parkinsons Dis; 2019; 9(4):793-802. PubMed ID: 31524179
    [TBL] [Abstract][Full Text] [Related]  

  • 79. β-amyloidopathy in the Pathogenesis of Age-Related Macular Degeneration in Correlation with Neurodegenerative Diseases.
    Ermilov VV; Nesterova AA
    Adv Exp Med Biol; 2016; 854():119-25. PubMed ID: 26427402
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.
    Robinson SR; Bishop GM
    Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.